Evolution of percutaneous coronary intervention in patients with diabetes: A report from the national heart, lung, and blood institute-sponsored PTCA (1985-1986) and dynamic (1997-2006) registries

Diabetes Care

Volumn 33, Issue 9, 2010, Pages 1976-1982

  Rana, Jamal S ^a   Venkitachalam, Lakshmi ^b   Selzer, Faith ^c   Mulukutla, Suresh R ^d   Marroquin, Oscar C ^d   Laskey, Warren K ^e   Holper, Elizabeth M ^f   Srinivas, Vankeepuram S ^g   Kip, Kevin E ^h   Kelsey, Sheryl F ^c   Nesto, Richard W ⁱ  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF NEW MEXICO   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g MONTEFIORE MEDICAL CENTER   (United States)

^h UNIVERSITY OF SOUTH FLORIDA   (United States)

ⁱ LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BARE METAL STENT; CARDIOGENIC SHOCK; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; DEATH; DEVICE THERAPY; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; REVASCULARIZATION; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; DIABETES MELLITUS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79951640450     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-0247     Document Type: Article

References (16)

1. Venkitachalam L, Kip KE, Selzer F, Wilensky RL, Slater J, Mulukutla SR, Marroquin OC, Block PC, Williams DO, Kelsey SF, Investigators of NHLBI-Sponsored 1985-1986 PTCA and 1997-2006 Dynamic Registries. Twenty-year evolution of percutaneous coronary intervention and its impact on clinical outcomes: a report from the NHLBI-sponsored, multicenter 1985-86 PTCA and 1997-2006 Dynamic Registries. Circ Cardiovasc Interv 2009;2:6-13
2. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Jüni P. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007;370:937-948 (Pubitemid 47393576)
3. Stein B, Weintraub WS, Gebhart SP, Cohen-Bernstein CL, Grosswald R, Liberman HA, Douglas JS Jr, Morris DC, King SB 3rd. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 1995;91:979-989
4. Abizaid A, Kornowski R, Mintz GS, Hong MK, Abizaid AS, Mehran R, Pichard AD, Kent KM, Satler LF, Wu H, Popma JJ, Leon MB. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998;32:584-589 (Pubitemid 28435240)
5. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:989-997 (Pubitemid 46376799)
6. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabaté M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schömig A. Analysis of 14 trials comparing sirolimus-luting stents with bare-metal stents. N Engl J Med 2007;356:1030-1039 (Pubitemid 46376803)
7. Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Currier JW. Coronary angioplasty in diabetic patients. The National Heart, Lung and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1996;94:1818-1825
8. Williams DO, Holubkov R, Yeh W, Bourassa MG, Al-Bassam M, Block PC, Coady P, Cohen H, Cowley M, Dorros G, Faxon D, Holmes DR, Jacobs A, Kelsey SF, King SB 3rd, Myler R, Slater J, Stanek V, Vlachos HA, Detre KM. Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung and Blood Institute Registries. Circulation 2000;102:2945-2951
9. Laskey WK, Williams DO, Vlachos HA, Cohen H, Holmes DR, King SB 3rd, Kelsey SF, Slater J, Faxon D, Al-Bassam M, Block E, Detre KM, Dynamic Registry Investigators. Changes in the practice of percutaneous coronary intervention: a comparison of enrollment waves in the National Heart, Lung, and Blood Institute (NHLBI) Dynamic Registry. Am J Cardiol 2001;87:964-969 (Pubitemid 32299980)
10. Kaul S, Shah PK, Diamond GA. As time goes by: current status and future directions in the controversy over stenting. J Am Coll Cardiol 2007;50:128-137 (Pubitemid 47002183)
11. James SK, Stenestrand U, Lindback J, Carlsson J, Schersten F, Nilsson T, Wallentin L, Lagerqvist B. SCAAR Study Group: Long-term safety and efficacy of drug-eluting versus baremetal stents in Sweden. N Engl J Med 2009;7;360:1933-1945
12. Abbott JD, Voss MR, Nakamura M, Cohen HA, Selzer F, Kip KE, Vlachos HA, Wilensky RL, Williams DO. Unrestricted use of drug-eluting stents compared with baremetal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry. J Am Coll Cardiol 2007;50:2029-2036 (Pubitemid 350087575)
13. Laskey WK, Selzer F, Vlachos HA, Johnston J, Jacobs A, King SB 3rd, Holmes DR, Douglas J, Block P, Wilensky R, Williams DO, Detre K, Dynamic Registry Inverstigators. Dynamic Registry Inverstigators. Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol 2002;90:1062-1067 (Pubitemid 35335594)
14. Mulukutla SR, Vlachos HA, Marroquin OC, Selzer F, Holper EM, Abbott JD, Laskey WK, Williams DO, Smith C, Anderson WD, Lee JS, Srinivas V, Kelsey SF, Kip KE. Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic Registry. JACC Cardiovasc Interv 2008;1:139-147 (Pubitemid 351506563)
15. Wolf WM, Vlachos HA, Marroquin OC, Lee JS, Smith C, Anderson WD, Schindler JT, Holper EM, Abbott JD, Williams DO, Laskey WK, Kip KE, Kelsey SF, Mulukutla SR. Paclitaxel-eluting versus sirolimus-eluting stents in diabetes mellitus: a report from the National Heart, Lung and Blood Institute Dynamic Registry. Circ Cardiovasc Interv 2010;3:42-49
16. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-2398